HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of data from X-ray screening program for coal workers to evaluate effectiveness of 2 mg/m3 coal dust standard.

Abstract
The National Institute for Occupational Safety and Health administers the X-ray Screening Program for underground coal miners, a program mandated by the Federal Mine Health and Safety Act of 1969. The screening file, with over 200,000 x-ray films, affords an excellent source for the study of prevalence and progression of Coal Workers' Pneumoconiosis. Two epidemiological analyses have recently been completed. One, a prevalence study of miners with 10 or fewer years of mining tenure, converted screening readings to median epidemiological readings. Converted prevalences were 0.44% for the group with 0 to 1 year tenure and 0.79% for the group with 1 to 9 years tenure. This result is similar to prevalence observed in a study of nonexposed blue collar workers. A second analysis reread x-ray films of a subgroup of 1,834 repeat miners with roughly 9 years exposure only under mandated dust standards. Net progression from category 0/0 was observed to be 1.2%. This value is consistent with 1.9%, based on an average dust exposure, predicted by British research. Results must be interpreted in light of several possible sources of bias.
AuthorsR Althouse, M Attfield, S Kellie
JournalJournal of occupational medicine. : official publication of the Industrial Medical Association (J Occup Med) Vol. 28 Issue 8 Pg. 741-5 (Aug 1986) ISSN: 0096-1736 [Print] United States
PMID3746499 (Publication Type: Journal Article)
Chemical References
  • Coal
  • Dust
Topics
  • Coal
  • Coal Mining
  • Dust (adverse effects)
  • Humans
  • Lung (diagnostic imaging)
  • Mass Screening
  • Maximum Allowable Concentration
  • Pneumoconiosis (diagnostic imaging, epidemiology, etiology, prevention & control)
  • Radiography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: